Commonwealth Equity Services’s Avid Bioservices, Inc. Common Stock CDMO Stock Holding History

Commonwealth Equity Services’s Portfolio CDMO Stock Details CDMO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q3	–	Sell	-10,482	Closed	-$159K	–	3782
2022 Q2	$159K	Sell	10,482 -35	-0.3%	-$518	﹤0.01%	3274
2022 Q1	$214K	Sell	10,517 -965	-8%	-$19.6K	﹤0.01%	3277
2021 Q4	$335K	Sell	11,482 -3,388	-23%	-$97K	﹤0.01%	2873
2021 Q3	$320K	Sell	14,870 -4,439	-23%	-$107K	﹤0.01%	2862
2021 Q2	$495K	Sell	19,309 -10,573	-35%	-$226K	﹤0.01%	2476
2021 Q1	$544K	Sell	29,882 -11,777	-28%	-$196K	﹤0.01%	2264
2020 Q4	$480K	Sell	41,659 -23	-0.1%	-$210	﹤0.01%	2172
2020 Q3	$317K	Sell	41,682 -835	-2%	-$6.32K	﹤0.01%	2312
2020 Q2	$279K	Sell	42,517 -239	-0.6%	-$1.33K	﹤0.01%	2328
2020 Q1	$218K	Sell	42,756 -1,292	-3%	-$7.82K	﹤0.01%	2314
2019 Q4	$337K	Sell	44,048 -6,455	-13%	-$37.7K	﹤0.01%	2218
2019 Q3	$267K	Sell	50,503 -588	-1%	-$3.65K	﹤0.01%	2344
2019 Q2	$286K	Buy	51,091 +1	+0%	+$4	﹤0.01%	2231
2019 Q1	$217K	Sell	51,090 -280	-0.5%	-$1.14K	﹤0.01%	2405
2018 Q4	$210K	Sell	51,370 -429	-0.8%	-$2.24K	﹤0.01%	2289
2018 Q3	$355K	Buy	51,799 +18	+0%	+$107	﹤0.01%	2034
2018 Q2	$203K	Sell	51,781 -1,680	-3%	-$5.83K	﹤0.01%	2455
2018 Q1	$156K	Sell	53,461 -858	-2%	-$2.65K	﹤0.01%	2464
2017 Q4	$211K	Sell	54,319 -3,600	-6%	-$15.4K	﹤0.01%	2330
2017 Q3	$182K	Sell	57,919 -2,832	-5%	-$10.6K	﹤0.01%	2316
2017 Q2	$259K	Buy	60,751 +1,071	+2%	+$4.38K	﹤0.01%	2030
2017 Q1	$273K	Buy	59,680 +643	+1%	+$2.15K	﹤0.01%	1919
2016 Q4	$127K	Buy	59,037 +7	+0%	+$16	﹤0.01%	2165
2016 Q3	$178K	Sell	59,030 -1,122	-2%	-$3.01K	﹤0.01%	2021
2016 Q2	$153K	Sell	60,152 -9,414	-14%	-$26.2K	﹤0.01%	2030
2016 Q1	$205K	Buy	69,566 +3,857	+6%	+$20.6K	﹤0.01%	1898
2015 Q4	$538K	Sell	65,709 -11,367	-15%	-$91.8K	0.01%	1241
2015 Q3	$550K	Sell	77,076 -143	-0.2%	-$1.19K	0.01%	1196
2015 Q2	$708K	Buy	77,219 +5,320	+7%	+$51.2K	0.01%	1146
2015 Q1	$679K	Buy	71,899 +1,043	+1%	+$10K	0.01%	1154
2014 Q4	$689K	Buy	70,856 +399	+0.6%	+$4.02K	0.01%	1089
2014 Q3	$671K	Sell	70,457 -27	-0%	-$302	0.01%	1066
2014 Q2	$928K	Sell	70,484 -1,714	-2%	-$21.6K	0.01%	905
2014 Q1	$960K	Buy	72,198 +3,464	+5%	+$45.6K	0.01%	820
2013 Q4	$669K	Buy	68,734 +571	+0.8%	+$5.37K	0.01%	989
2013 Q3	$668K	Sell	68,163 -1,898	-3%	-$18.9K	0.01%	932
2013 Q2	$633K	Buy	+70,061	New	+$734K	0.01%	914

Other funds holding CDMO

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return

AltraVue Capital Bellevue, Washington $1.16B AUM 46.45% 1-Year Est. Return

RIM

Ranger Investment Management Dallas, Texas $1.38B AUM 24.55% 1-Year Est. Return

SCM

Snyder Capital Management San Francisco, California $5.16B AUM 26.72% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return

Commonwealth Equity Services's CDMO Position: Q3 2022 in Review

Commonwealth Equity Services sold out of Avid Bioservices, Inc. Common Stock (CDMO) in Q3 2022, closing a stake of 10,482 shares — an estimated $159K sold.

Commonwealth Equity Services first reported a position in CDMO in Q2 2013 and held it in 37 quarters. The position peaked at $960K in Q1 2014. 184 funds tracked by Wall St. Rank hold CDMO as of Q3 2022.

Commonwealth Equity Services reported no remaining Avid Bioservices, Inc. Common Stock position as of Q3 2022 after selling out during the quarter.
Commonwealth Equity Services sold 10,482 Avid Bioservices, Inc. Common Stock shares in Q3 2022, an estimated $159K.
Commonwealth Equity Services first reported a position in Avid Bioservices, Inc. Common Stock in Q2 2013 and held it in 37 quarters.
Commonwealth Equity Services's Avid Bioservices, Inc. Common Stock position peaked at $960K in Q1 2014.
184 funds tracked by Wall St. Rank held Avid Bioservices, Inc. Common Stock as of Q3 2022.

Based on Commonwealth Equity Services's 13F filing for Q3 2022, filed 14 Nov 2022.